Federal investigators have widened the scope of the ongoing investigation into the death of actress Hayden Panettiere, focusing on a potential source of counterfeit oxycodone in Southern California. The Los Angeles Times reported that the Drug Enforcement Administration (DEA) and local law‑enforcement agencies are interviewing several individuals about the circumstances surrounding the tragedy.

Details of the incident

On August 16, emergency responders answered a 911 call at an apartment in Greenville, South Carolina. Paramedics found Panettiere, 36, in cardiac arrest and were unable to revive her. The Greenville County coroner has not released an official autopsy report, citing pending toxicology results that will determine the cause and manner of death.

Federal involvement

According to sources familiar with the investigation, DEA agents and Los Angeles‑area authorities have begun questioning people who may have knowledge of a drug transaction involving a Southern California dealer. The focus is on whether Panettiere obtained what officials describe as “counterfeit oxycodone,” a potent opioid that has been linked to numerous overdose deaths across the country.

Panettiere’s public health history

Panettiere, whose career began before she turned one year old, has been open about her struggles with depression and substance‑use disorder. Her candid discussions have resonated with many families dealing with similar challenges, underscoring the importance of compassionate mental‑health resources and addiction treatment.

Ongoing investigation

Federal agencies, including the DEA and the FBI, have not provided additional comment beyond confirming that the investigation is active. Local authorities in both Los Angeles and Greenville have also declined to elaborate, citing the sensitivity of the case.

What this means for the community

The investigation highlights the broader issue of counterfeit prescription drugs circulating in the United States. Health officials continue to warn that counterfeit opioids often contain dangerous substances such as fentanyl, dramatically increasing the risk of fatal overdose. Families and community leaders are urged to remain vigilant, seek reputable medical guidance, and support local addiction‑recovery programs.

Next steps

As toxicology results become available, the coroner’s office is expected to release a formal report detailing the findings. Until then, authorities are urging anyone with information about the alleged drug source to contact law‑enforcement.

This story will be updated as new details emerge.

Original reporting: El Paso News (HLL/CB) — read the source article.